E-LIB Suche - Ergebnisse für: Jackson, Camille Gunderson

1

NRG‐GY012: Randomized phase 2 study comparing olaparib, ced..:

Rimel, Bobbie J. ; Enserro, Danielle ; Bender, David P....
Cancer. 130 (2023) 8 - p. 1234-1245 , 2023

Link: https://doi.org/10.1002/..

2

DKK1 is a predictive biomarker for response to DKN-01: Resu..:

Arend, Rebecca ; Dholakia, Jhalak ; Castro, Cesar...
Gynecologic Oncology. 172 (2023) - p. 82-91 , 2023

Link: https://doi.org/10.1016/..

3

Progression-free survival by investigator versus blinded in..:

Aghajanian, Carol ; Bookman, Michael A. ; Fleming, Gini F....
Gynecologic Oncology. 162 (2021) 2 - p. 375-381 , 2021

Link: https://doi.org/10.1016/..

4

RaPiDS (GOG-3028): Randomized Phase II Study of Balstilimab..:

O'Malley, David M ; Randall, Leslie M ; Jackson, Camille Gunderson...
Future Oncology. 17 (2021) 26 - p. 3433-3443 , 2021

Link: https://doi.org/10.2217/..

5

Mixed clear cell/endometrioid and clear cell/serous carcino..:

Hagemann, Ian S. ; Deng, Wei ; Zaino, Richard J....
Gynecologic Oncology. 177 (2023) - p. 38-45 , 2023

Link: https://doi.org/10.1016/..

6

Recurrence risk of occult micrometastases and isolated tumo..:

Castellano, Tara ; Hassell, Lewis ; Conrad, Rachel...
Gynecologic Oncology Reports. 37 (2021) - p. 100846 , 2021

Link: https://doi.org/10.1016/..

7

GEN-1 in Combination with Neoadjuvant Chemotherapy for Pati..:

Thaker, Premal H. ; Bradley, William H. ; Leath III, Charles A....
Clinical Cancer Research. 27 (2021) 20 - p. 5536-5545 , 2021

Link: https://doi.org/10.1158/..

8

Progression-free survival by investigator versus blinded in..:

Aghajanian, Carol ; Bookman, Michael A ; Fleming, Gini F...
Aghajanian , C , Bookman , M A , Fleming , G F , Swisher , E M , Steffensen , K D , Friedlander , M , Okamoto , A , Jackson , C G , Sullivan , D , Ratajczak , C K & Coleman , R L 2021 , ' Progression-free survival by investigator versus blinded independent central review in newly diagnosed patients with high-grade serous ovarian cancer : Analysis of the VELIA/GOG-3005 trial ' , Gynecologic Oncology , vol. 162 , no. 2 , pp. 375-381 . https://doi.org/10.1016/j.ygyno.2021.05.031. , 2021

Link: https://portal.findresea..

9

Patient-Derived Xenografts of High-Grade Serous Ovarian Can..:

Cybula, Magdalena ; Wang, Lin ; Wang, Luyao...
Cancers. 13 (2021) 24 - p. 6288 , 2021

Link: https://doi.org/10.3390/..

10

Recurrence risk of occult micrometastases and isolated tumo..:

Castellano, Tara ; Hassell, Lewis ; Conrad, Rachel...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385390/. , 2021

Link: http://www.ncbi.nlm.nih...

11

Recurrence risk of occult micrometastases and isolated tumo..:

Tara Castellano ; Lewis Hassell ; Rachel Conrad...
http://www.sciencedirect.com/science/article/pii/S2352578921001508. , 2021

Link: https://doi.org/10.1016/..

12

Infographic: RaPiDS (GOG-3028): randomized Phase II study o..:

David M O'Malley (11301444) ; Leslie M Randall (11301445) ; Camille Gunderson Jackson (11301448)...
https://figshare.com/articles/figure/Infographic_RaPiDS_GOG-3028_randomized_Phase_II_study_of_balstilimab_alone_or_in_combination_with_zalifrelimab_in_cervical_cancer/15367260. , 2021

Link: https://doi.org/10.25402..

13

Patient-Derived Xenografts of High-Grade Serous Ovarian Can..:

Magdalena Cybula ; Lin Wang ; Luyao Wang...
Methods and Technologies Development. , 2021

Link: https://doi.org/10.3390/..

14

Patient-Derived Xenografts of High-Grade Serous Ovarian Can..:

Magdalena Cybula ; Lin Wang ; Luyao Wang...
https://www.mdpi.com/2072-6694/13/24/6288. , 2021

Link: https://doi.org/10.3390/..

15

Patient-Derived Xenografts of High-Grade Serous Ovarian Can..:

Cybula, Magdalena ; Wang, Lin ; Wang, Luyao...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699796/. , 2021

Link: http://www.ncbi.nlm.nih...